203 related articles for article (PubMed ID: 19357348)
1. Nuclear localization of active HGF receptor Met in aggressive MDA-MB231 breast carcinoma cells.
Matteucci E; Bendinelli P; Desiderio MA
Carcinogenesis; 2009 Jun; 30(6):937-45. PubMed ID: 19357348
[TBL] [Abstract][Full Text] [Related]
2. HGF and TGFβ1 differently influenced Wwox regulatory function on Twist program for mesenchymal-epithelial transition in bone metastatic versus parental breast carcinoma cells.
Bendinelli P; Maroni P; Matteucci E; Desiderio MA
Mol Cancer; 2015 Jun; 14():112. PubMed ID: 26041563
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of HGF on invasiveness of aggressive MDA-MB231 breast carcinoma cells, and role of HDACs.
Ridolfi E; Matteucci E; Maroni P; Desiderio MA
Br J Cancer; 2008 Nov; 99(10):1623-34. PubMed ID: 18941460
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic regulation of HGF/Met receptor axis is critical for the outgrowth of bone metastasis from breast carcinoma.
Bendinelli P; Maroni P; Matteucci E; Desiderio MA
Cell Death Dis; 2017 Feb; 8(2):e2578. PubMed ID: 28151481
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia induced E-cadherin involving regulators of Hippo pathway due to HIF-1α stabilization/nuclear translocation in bone metastasis from breast carcinoma.
Maroni P; Matteucci E; Drago L; Banfi G; Bendinelli P; Desiderio MA
Exp Cell Res; 2015 Jan; 330(2):287-299. PubMed ID: 25447306
[TBL] [Abstract][Full Text] [Related]
6. Interaction between human-breast cancer metastasis and bone microenvironment through activated hepatocyte growth factor/Met and beta-catenin/Wnt pathways.
Previdi S; Maroni P; Matteucci E; Broggini M; Bendinelli P; Desiderio MA
Eur J Cancer; 2010 Jun; 46(9):1679-91. PubMed ID: 20350802
[TBL] [Abstract][Full Text] [Related]
7. c-Src/histone deacetylase 3 interaction is crucial for hepatocyte growth factor dependent decrease of CXCR4 expression in highly invasive breast tumor cells.
Matteucci E; Ridolfi E; Maroni P; Bendinelli P; Desiderio MA
Mol Cancer Res; 2007 Aug; 5(8):833-45. PubMed ID: 17699109
[TBL] [Abstract][Full Text] [Related]
8. Expression of the c-Met/HGF receptor in human breast carcinoma: correlation with tumor progression.
Beviglia L; Matsumoto K; Lin CS; Ziober BL; Kramer RH
Int J Cancer; 1997 Jun; 74(3):301-9. PubMed ID: 9221809
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte growth factor differently influences Met-E-cadherin phosphorylation and downstream signaling pathway in two models of breast cells.
Matteucci E; Ridolfi E; Desiderio MA
Cell Mol Life Sci; 2006 Sep; 63(17):2016-26. PubMed ID: 16909210
[TBL] [Abstract][Full Text] [Related]
10. Breast tumor kinase and extracellular signal-regulated kinase 5 mediate Met receptor signaling to cell migration in breast cancer cells.
Castro NE; Lange CA
Breast Cancer Res; 2010; 12(4):R60. PubMed ID: 20687930
[TBL] [Abstract][Full Text] [Related]
11. Functions and Epigenetic Regulation of Wwox in Bone Metastasis from Breast Carcinoma: Comparison with Primary Tumors.
Maroni P; Matteucci E; Bendinelli P; Desiderio MA
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28045433
[TBL] [Abstract][Full Text] [Related]
12. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
[TBL] [Abstract][Full Text] [Related]
13. The SPRY domain-containing SOCS box protein 1 (SSB-1) interacts with MET and enhances the hepatocyte growth factor-induced Erk-Elk-1-serum response element pathway.
Wang D; Li Z; Messing EM; Wu G
J Biol Chem; 2005 Apr; 280(16):16393-401. PubMed ID: 15713673
[TBL] [Abstract][Full Text] [Related]
14. In bone metastasis miR-34a-5p absence inversely correlates with Met expression, while Met oncogene is unaffected by miR-34a-5p in non-metastatic and metastatic breast carcinomas.
Maroni P; Puglisi R; Mattia G; Carè A; Matteucci E; Bendinelli P; Desiderio MA
Carcinogenesis; 2017 May; 38(5):492-503. PubMed ID: 28334277
[TBL] [Abstract][Full Text] [Related]
15. Bone metastatic process of breast cancer involves methylation state affecting E-cadherin expression through TAZ and WWOX nuclear effectors.
Matteucci E; Maroni P; Luzzati A; Perrucchini G; Bendinelli P; Desiderio MA
Eur J Cancer; 2013 Jan; 49(1):231-44. PubMed ID: 22717556
[TBL] [Abstract][Full Text] [Related]
16. SRC kinase activator CDCP1 promotes hepatocyte growth factor-induced cell migration/invasion of a subset of breast cancer cells.
Kawase N; Sugihara A; Kajiwara K; Hiroshima M; Akamatsu K; Nada S; Matsumoto K; Ueda M; Okada M
J Biol Chem; 2022 Mar; 298(3):101630. PubMed ID: 35085554
[TBL] [Abstract][Full Text] [Related]
17. Microenvironment Stimuli HGF and Hypoxia Differently Affected miR-125b and Ets-1 Function with Opposite Effects on the Invasiveness of Bone Metastatic Cells: A Comparison with Breast Carcinoma Cells.
Matteucci E; Maroni P; Nicassio F; Ghini F; Bendinelli P; Desiderio MA
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29337876
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of co-expression of RON and MET receptors in node-negative breast cancer patients.
Lee WY; Chen HH; Chow NH; Su WC; Lin PW; Guo HR
Clin Cancer Res; 2005 Mar; 11(6):2222-8. PubMed ID: 15788670
[TBL] [Abstract][Full Text] [Related]
19. Distinct recruitment of Eps15 via Its coiled-coil domain is required for efficient down-regulation of the met receptor tyrosine kinase.
Parachoniak CA; Park M
J Biol Chem; 2009 Mar; 284(13):8382-94. PubMed ID: 19109251
[TBL] [Abstract][Full Text] [Related]
20. The multisubstrate adapter Gab1 regulates hepatocyte growth factor (scatter factor)-c-Met signaling for cell survival and DNA repair.
Fan S; Ma YX; Gao M; Yuan RQ; Meng Q; Goldberg ID; Rosen EM
Mol Cell Biol; 2001 Aug; 21(15):4968-84. PubMed ID: 11438654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
